Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalt Pharma is an Italian contract development and manufacturing organization (CDMO) specializing in the production of oral solid dosage forms for the pharmaceutical, nutraceutical, and medical device industries. Founded in 2004 and based in Seregno, the company provides end-to-end services including formulation development, pilot-scale trials, industrial manufacturing, and primary and secondary packaging. Their GMP-certified facility is equipped to produce a variety of formats such as film-coated tablets, sugar-coated tablets, hard-gel capsules, and powders in sachets. Dalt Pharma focuses on high-quality standards and regulatory compliance, supporting global clients from the research and development phase through to commercial distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalt Pharma.